Jerry D Glickson Selected Research

Breast Neoplasms (Breast Cancer)

3/2015	Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin.
2/2014	Is higher lactate an indicator of tumor metastatic risk? A pilot MRS study using hyperpolarized (13)C-pyruvate.
5/2010	Quantitative mitochondrial redox imaging of breast cancer metastatic potential.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jerry D Glickson Research Topics

Disease

49	Neoplasms (Cancer) 01/2024 - 05/2002
15	Melanoma (Melanoma, Malignant) 01/2024 - 03/2004
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2013 - 12/2007
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2011 - 08/2008
4	Hyperthermia 06/2023 - 01/2013
3	Breast Neoplasms (Breast Cancer) 03/2015 - 05/2010
3	Hyperglycemia 03/2015 - 01/2003
3	Hepatoblastoma 04/2011 - 05/2002
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 12/2005 - 06/2002
3	Experimental Melanoma 05/2005 - 06/2004
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 01/2019
2	Lymphoma (Lymphomas) 01/2016 - 01/2013
2	Carcinoma (Carcinomatosis) 03/2015 - 05/2005
2	Hepatocellular Carcinoma (Hepatoma) 04/2014 - 09/2012
2	Glioma (Gliomas) 07/2005 - 07/2003
2	Fibrosarcoma 12/2003 - 04/2003
1	T-Cell Lymphoma (Lymphoma, T Cell) 12/2023
1	Ovarian Neoplasms (Ovarian Cancer) 03/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2013
1	Ischemia 12/2009
1	Neoplasm Metastasis (Metastasis) 04/2009

Drug/Important Bio-Agent (IBA)

19	Lactic Acid (Lactate)FDA LinkGeneric 12/2022 - 01/2003
9	lonidamineIBA 06/2023 - 01/2013
8	NAD (NADH)IBA 12/2023 - 12/2003
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 04/2003
8	oxidized low density lipoproteinIBA 04/2011 - 05/2002
7	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 01/2003
7	LDL Receptors (LDL Receptor)IBA 12/2005 - 05/2002
6	LDL Lipoproteins (beta Lipoproteins)IBA 04/2011 - 05/2002
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 08/2008
5	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2018 - 12/2007
5	Melphalan (Alkeran)FDA LinkGeneric 01/2016 - 03/2004
5	NucleosidesIBA 03/2015 - 12/2007
5	FlavoproteinsIBA 01/2013 - 01/2007
5	Vincristine (Oncovin)FDA LinkGeneric 01/2011 - 12/2007
5	Prednisone (Sone)FDA LinkGeneric 01/2011 - 12/2007
5	LipidsIBA 07/2010 - 05/2002
4	Adenosine Triphosphate (ATP)IBA 01/2016 - 03/2015
4	triphosphoric acid (triphosphate)IBA 03/2015 - 12/2007
4	Choline (Choline Chloride)IBA 01/2011 - 12/2007
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2005
3	Phosphotransferases (Kinase)IBA 12/2023 - 01/2013
3	Pyruvic Acid (Pyruvate)IBA 06/2023 - 01/2016
3	Antineoplastic Agents (Antineoplastics)IBA 11/2017 - 03/2015
3	Alkylating AgentsIBA 01/2016 - 04/2003
3	Phosphates (Orthophosphate)IBA 03/2015 - 01/2011
3	Photosensitizing Agents (Photosensitizers)IBA 04/2011 - 05/2002
3	Contrast MediaIBA 03/2008 - 08/2004
2	EnzymesIBA 12/2023 - 01/2013
2	Temozolomide (Temodar)FDA LinkGeneric 01/2017 - 07/2005
2	Protons (Proton)IBA 12/2016 - 01/2003
2	Sirolimus (Rapamycin)FDA Link 01/2016 - 01/2013
2	Mechlorethamine (Nitrogen Mustard)FDA Link 01/2016 - 03/2015
2	Glutamic Acid (Glutamate)FDA Link 01/2016 - 12/2003
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2016 - 09/2013
2	A-factor (Streptomyces)IBA 03/2015 - 08/2004
2	Indicators and Reagents (Reagents)IBA 02/2014 - 08/2008
2	Rituximab (Mabthera)FDA Link 01/2011 - 04/2009
2	pyridineIBA 04/2009 - 01/2007
2	NucleotidesIBA 04/2009 - 01/2007
2	bryostatin 1IBA 11/2008 - 12/2007
2	benthiocarb (Bolero)IBA 01/2007 - 08/2004
2	Phosphorylcholine (Phosphocholine)IBA 07/2005 - 04/2003
2	3-Iodobenzylguanidine (Iobenguane)IBA 03/2004 - 01/2003
2	Perchloric AcidIBA 12/2003 - 04/2003
1	dabrafenibIBA 01/2024
1	BuffersIBA 06/2023
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 06/2023
1	Alanine (L-Alanine)FDA Link 12/2022
1	CytokinesIBA 01/2019
1	ibrutinibIBA 01/2019
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2019
1	Monocarboxylic Acid TransportersIBA 12/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	malic acid (malate)IBA 01/2016
1	diphosphoric acid (pyrophosphoric acid)IBA 01/2016
1	Bendamustine Hydrochloride FDA Link 01/2016
1	Carboxylic AcidsIBA 01/2016
1	Chlorambucil (Leukeran)FDA Link 01/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2016
1	GlycogenIBA 01/2016
1	IndazolesIBA 01/2016
1	PentosesIBA 01/2016
1	TOR Serine-Threonine KinasesIBA 01/2016
1	Carbonic AcidIBA 03/2015
1	AnthracyclinesIBA 03/2015
1	Carbon DioxideIBA 03/2015
1	IsotopesIBA 04/2014
1	Aspartic Acid (Aspartate)FDA Link 04/2014
1	phosphorylethanolamine (phosphoethanolamine)IBA 09/2013
1	Phosphorus (Red Phosphorus)IBA 09/2013
1	Oxygen (Dioxygen)IBA 09/2012
1	bacteriochlorinIBA 04/2011

Therapy/Procedure

14	Therapeutics 01/2024 - 01/2003
11	Drug Therapy (Chemotherapy) 06/2023 - 06/2002
4	Photochemotherapy (Photodynamic Therapy) 06/2023 - 07/2003
4	Radiotherapy 06/2023 - 06/2002
2	Combination Drug Therapy (Combination Chemotherapy) 11/2008 - 12/2007
1	Time-to-Treatment 09/2013
1	Aftercare (After-Treatment) 04/2009